Position in RCEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$194,479
-$24,264 QoQ
Shares Held
52,562
+22.8% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. RCEL ranks #51 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,611,020 | $226,591,504 | |
| 2 | SYK |
Stryker Corp
|
630,236 | $207,089,246 | |
| 3 | ABT |
Abbott Laboratories
|
2,010,938 | $206,463,003 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,996,377 | $159,869,868 | |
| 5 | PODD |
Insulet Corp
|
606,482 | $127,264,182 | |
| 6 | GMED |
Globus Medical Inc
|
562,630 | $48,476,200 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
1,442,472 | $27,652,186 | |
| 8 | HAE |
Haemonetics Corp
|
320,010 | $18,035,762 |
All Filings in RCEL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,479 | 52,562 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $218,743 | 42,807 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $406,404 | 76,825 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $928,708 | 114,092 | Shares | Other | 2025-05-15 | |
| 2023-09-30 | $195,861 | 13,406 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $433,755 | 25,500 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $862,158 | 61,715 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $418,928 | 63,474 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $76,367 | 14,491 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||